Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PR › Hatillo › NPI 1609942093

Vega Rodriguez, Aixa

Vega Rodriguez, Aixa was paid $95K by Medicaid between Jan 2018 and Oct 2024, across 10 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 25% of everything it billed.

33Billing provider infoVEGA RODRIGUEZ, AIXA
HATILLO, PR 00659
33aNPI1609942093assigned 11/28/2006
33bProvider typeMedical Technologist
28Total paid$95K
24GClaims9,958
24DCodes billed10
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers

Next to other Medical Technologist providers in Puerto Rico

Rank by total paid#4 of 9
Median peer was paid$76K
This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,002$18K
20191,507$14K
2020920$9K
20211,607$16K
20221,458$14K
20231,224$11K
2024incomplete1,240$13K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
84443 Thyroid stimulating hormone (TSH) 25% 1,507 1,451 $23K
80061 Lipid panel 22% 1,692 1,612 $21K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 16% 2,134 2,017 $15K
80053 Comprehensive metabolic panel 16% 1,539 1,476 $15K
83036 Hemoglobin; glycosylated (A1C) 6.7% 719 703 $6K
81000 5.2% 1,717 1,649 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4.9% 177 164 $5K
82274 3.2% 205 200 $3K
82043 1.4% 230 225 $1K
36415 Collection of venous blood by venipuncture <1% 38 37 $98.22

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.